// App-Quantinova.ai

O11 : Lymphocyte DNA methylation mediates genetic risk at RA risk loci that are shared with other immune mediated diseases

Researchers

Presenter

  • Alexander D Clark

Principal Investigators

  • Nisha Nair

  • Amy E Anderson

  • Nishanthi Thalayasingam

  • Najib Naamane

  • Andrew J Skelton

  • Julie Diboll

  • Anne Barton

  • Stephen Eyre

  • John D Isaacs

  • Louise N Reynard

  • Arthur G Pratt

Medical Centers

  • Institute of Cellular Medicine Musculoskeletal Research Group, Newcastle University, UK

  • Versus Arthritis Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, Manchester University, Manchester, UNITED KINGDOM

  • NIHR Manchester Musculoskeletal BRC, Manchester University NHS Foundation Trust, Manchester, UNITED KINGDOM

  • Musculoskeletal Services Directorate, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UNITED KINGDOM

  • Bioinformatics Support Unit, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UNITED KINGDOM

  • Institute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

Biomarkers

  • Cluster of Differentiation 4

  • DNA methylation

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved